Prelude Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Prelude Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,900	Closed	-$459K	–	2282
2019 Q2	$459K	Buy	+9,900	New	+$278K	0.02%	518

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Prelude Capital Management's ARRY Position: Q3 2019 in Review

Prelude Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 564,244 shares — an estimated $26.1M sold.

Prelude Capital Management first reported a position in ARRY in Q1 2014 and held it in 14 quarters. The position peaked at $26.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Prelude Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Prelude Capital Management sold 564,244 Array Biopharma Inc shares in Q3 2019, an estimated $26.1M.
Prelude Capital Management first reported a position in Array Biopharma Inc in Q1 2014 and held it in 14 quarters.
Prelude Capital Management's Array Biopharma Inc position peaked at $26.1M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.